LD-2 disclosure · 2nd Quarter - Report
VIR BIOTECHNOLOGY, INC.
via VIR BIOTECHNOLOGY, INC.
Client
- Name
- VIR BIOTECHNOLOGY, INC.
- Location
- California · United States of America
Registrant
- Firm
- VIR BIOTECHNOLOGY, INC.
- Description
- Commercial-stage immunology company
- Location
- San Francisco, California, United States of America
Lobbying activities
4 issuesHealth Issues
S. 3799 PREVENT Pandemics Act; Pandemic Preparedness Funding; COVID-19 Response and COVID-19 Therapeutics Procurement; S. 2640 Disease X Act; S. 3258/H.R. 6025 Flu Vaccine Act; FY 2023 Labor-HHS Appropriations.
LobbyistsDOUGLAS STOSS
TargetedSENATE · HOUSE OF REPRESENTATIVES · Office of Science & Technology Policy (OSTP) · Health & Human Services, Dept of (HHS)
Science/Technology
Pandemic Preparedness
LobbyistsDOUGLAS STOSS
TargetedSENATE · HOUSE OF REPRESENTATIVES · Office of Science & Technology Policy (OSTP) · Health & Human Services, Dept of (HHS) · Natl Institutes of Health (NIH)
Medicare/Medicaid
Coverage and Reimbursement of COVID-19 Therapeutics.
LobbyistsDOUGLAS STOSS
TargetedSENATE · HOUSE OF REPRESENTATIVES · Centers For Medicare and Medicaid Services (CMS)
